Skip to main content
OpenTrials

Clinical trial condition

Immune System Diseases

Explore clinical trials studying Immune System Diseases. Study availability and eligibility vary by location and protocol.

323 public trials 61 recruiting studies
Refine in advanced search Browse all conditions

Immune System Diseases trial results

Active, not recruiting

A Clinical Trial to Evaluate the Safety and Immunogenicity of BG505 MD39.3, BG505 MD39.3 gp151, and BG505 MD39.3 gp151 CD4KO HIV Trimer mRNA Vaccines in Healthy, HIV-uninfected Adult Participants

NCT05217641

Conditions
Blood-Borne Infections, Communicable Diseases, Disease Attributes, +14 more
Locations
  • Alabama CRS [31788] Birmingham, Alabama, United States
  • UCLA Vine Street Clinic CRS [31607] Los Angeles, California, United States
  • Bidmc Vcrs [32077] Boston, Massachusetts, United States
  • Brigham and Women's Hospital Vaccine CRS [30007] Boston, Massachusetts, United States
View Trial Details
Active, not recruiting

Safety Study of Zinc Finger Nuclease CCR5-modified Hematopoietic Stem/Progenitor Cells in HIV-1 Infected Patients

NCT02500849

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +17 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • UCLA CARE Center Los Angeles, California, United States
  • Mills Clinical Research Los Angeles, California, United States
  • Quest Clinical Research San Francisco, California, United States
View Trial Details
Active, not recruiting

Study of TBI-1501 for Relapsed or Refractory Acute Lymphoblastic Leukemia

NCT03155191

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations
  • Akita University Hospital Akita, Japan
  • University Of Fukui Hospital Yoshida, Fukui, Japan
  • Kyushu University Hospital Higashiku, Fukuoka, Japan
  • Hokkaido University Hospital Sapporo, Hokkaido, Japan
View Trial Details
Completed

DPX-Survivac and Checkpoint Inhibitor in DLBCL

NCT03349450

Conditions
Adult Diffuse Large Cell Lymphoma, Adult Refractory Diffuse Large B-Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, +18 more
Locations
  • Tom Baker Cancer Centre - Alberta Health Services Calgary, Alberta, Canada
  • Nova Scotia Health Authority: Queen Elizabeth II Health Sciences Centre Halifax, Nova Scotia, Canada
  • London Health Sciences Centre London, Ontario, Canada
  • Ottawa Hospital Research Institute Ottawa, Ontario, Canada
View Trial Details
Completed

Abrocitinib Taiwan Treatment Pattern and Real World Study in ATopiC Dermatitis (ATTRACT Registry)

NCT06353087

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +10 more
Locations
  • Kaohsiung Medical University Hospital Kaohsiung City, Taiwan
  • Chang Gung Memorial Hospital at Kaohsiung Kaohsiung City, Taiwan
  • Taipei Medical University - Shuang Ho Hospital New Taipei City, Taiwan
  • NTUH Taipei, Taiwan
View Trial Details
Completed

Dose Escalation Trial Of Safety, Pharmacokinetic/Pharmacodynamic And Preliminary Clinical Activity of Briquilimab In Adult Patients With Chronic Spontaneous Urticaria (CSU)

NCT06162728

Conditions
Chronic Disease, Chronic Spontaneous Urticaria, Chronic Urticaria, +13 more
Locations
  • Site 118 Birmingham, Alabama, United States
  • Site 108 Little Rock, Arkansas, United States
  • Site 105 San Diego, California, United States
  • Site 113 Miami, Florida, United States
View all 23 locations
View Trial Details
Completed

HIV Engagement and Adolescent Depression Support (HEADS-UP)

NCT06173544

Conditions
Adolescent Behavior, Anxiety, Anxiety Disorders, +18 more
Locations
  • Area 18 Health Centre Lilongwe, Malawi
  • Area 25 Health Centre Lilongwe, Malawi
  • Kawale Health Centre Lilongwe, Malawi
  • Lighthouse Health Centre Lilongwe, Malawi
View Trial Details

Related conditions